Spotlight: Chinese biotech chooses NY CRO for cancer trial

Beverly Hills, CA, cancer biopharma company Rich Pharmaceuticals has extended its agreement with Princeton, NJ-based CRO Theradex Systems to manage its clinical sites in the U.S. Through this continued deal, Theradex will lead Rich Pharma's new Phase I/II clinical for the treatment of acute myelocytic leukemia and myelodysplastic syndrome patients in the region. Release

> China-based biotech Henlius has chosen NY cloud software CRO Medidata to help it bring "operational efficiencies" to its ongoing Phase III cancer drug trial in its native country. Release

> HealthCarePoint, a Texas-based healthcare and clinical research networking-tech company, has completed global testing of its next-gen BlueCloud business model to help healthcare groups and CROs better manage clinical trials. Release